The FDA Modernization Act of 1997 established the Fast Track designation to expedite developing and reviewing new drugs ...

Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...

Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats ...

It should come as no surprise that the Tennessee Bureau of Investigation wants to cut down on illicit drug use. What perhaps ...

A Norwich man with a long history of dealing drugs claims police were illegally tracking his activities prior to his most recent arrest on felony narcotic trafficking charges. Bennie Gray Jr., 45, who ...

Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's ...

FLQ-101 is still an investigational medicine and has not yet been approved by regulatory authorities. "FDA grants fast track ...

The FDA allows companies to produce and market compounded ... Hims & Hers (HIMS) said it has been communicating information compiled through the tracker to state and federal agencies.

FELIQS plans to conduct a Phase 1b/2 study of FLQ-101 (tROPhy-1 study) both in the US and Japan in the first quarter of 2025.

Hims & Hers (HIMS) is launching a new GLP-1 tracker in its efforts to fight back against the FDA’s decision to end compounded ...